VALIANT LABORATORIES
Back to All Ratios
|
VALIANT LABORATORIES Last 5 Year Fixed Capital/Sales History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Fixed Capital/Sales(x) | 0.37 | 0.20 |
What is the latest Fixed Capital/Sales ratio of VALIANT LABORATORIES ?
Year | Fixed Capital/Sales |
---|---|
Mar2024 | 0.37 |
Mar2023 | 0.20 |
How is Fixed Capital/Sales of VALIANT LABORATORIES Trending?
Years | Fixed Capital/Sales | % Change | |
---|---|---|---|
Mar2024 | 0.37 | 85.00 | |
Mar2023 | 0.2 | - |
Other Financial Ratios of VALIANT LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Fixed Capital/Sales ratio of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹413.3 Cr | -7.9% | -13.9% | -43.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -7.9% |
-13.9% |
-43.3% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses